Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-005908
Filing Date
2022-02-01
Accepted
2022-02-01 16:18:58
Documents
1
Period of Report
2022-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5768
  Complete submission text file 0001209191-22-005908.txt   7111
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Issuer) CIK: 0001600847 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 17 STATE STREET 7TH FLOOR NEW YORK NY 10004
Business Address
Korfin Michele Ilene (Reporting) CIK: 0001771664 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38716 | Film No.: 22579161